Ted Cecconie

机构：South College, GlaxoSmithKline (United States)

发表论文 6 篇 · 总被引 174 次 · h-index 5

代表论文

• Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors (2015 · ACS Medicinal Chemistry Letters · 被引 89)
• Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen Presentation (2020 · Journal of Medicinal Chemistry · 被引 45)
• Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening (2022 · Journal of Medicinal Chemistry · 被引 18)
• Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1 (2024 · Journal of Biological Chemistry · 被引 12)
• Discovery and SAR Study of Boronic Acid-Based Selective PDE3B Inhibitors from a Novel DNA-Encoded Library (2024 · Journal of Medicinal Chemistry · 被引 10)
• Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1 in HepG2 cells (2023 · bioRxiv (Cold Spring Harbor Laboratory))